American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$272M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$237M |
| 3 |
Kenvue
KVUE
|
+$236M |
| 4 |
Norfolk Southern
NSC
|
+$219M |
| 5 |
Amazon
AMZN
|
+$173M |
Top Sells
| 1 |
Marvell Technology
MRVL
|
+$230M |
| 2 |
Walt Disney
DIS
|
+$193M |
| 3 |
Advanced Micro Devices
AMD
|
+$165M |
| 4 |
Johnson & Johnson
JNJ
|
+$153M |
| 5 |
MarketAxess Holdings
MKTX
|
+$148M |
Sector Composition
| 1 | Technology | 23.05% |
| 2 | Healthcare | 13.44% |
| 3 | Financials | 13.33% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Annexon
ANNX
$252M
| $57K | ﹤0.01% |
24,169
+5,041
| +26% | +$11.9K |
|
2702
Sensus Healthcare
SRTS
$52.6M
| $56.8K | ﹤0.01% |
20,516
| – | – |
|
2703
Gannett
GCI
$601M
| $56.4K | ﹤0.01% |
23,015
+12,862
| +127% | +$31.5K |
|
2704
Altimmune
ALT
$326M
| $55.3K | ﹤0.01% |
21,264
+10,093
| +90% | +$26.2K |
|
2705
Sight Sciences
SGHT
$179M
| $53.6K | ﹤0.01% |
15,908
+5,370
| +51% | +$18.1K |
|
2706
Codexis
CDXS
$219M
| $52.9K | ﹤0.01% |
28,001
+7,973
| +40% | +$15.1K |
|
2707
Purple Innovation
PRPL
$116M
| $51.7K | ﹤0.01% |
30,205
+10,731
| +55% | +$18.4K |
|
2708
BlackSky Technology
BKSY
$617M
| $51.5K | ﹤0.01% |
+5,499
| New | +$51.5K |
|
2709
Cue Biopharma
CUE
$58.6M
| $50K | ﹤0.01% |
21,758
+9,713
| +81% | +$22.3K |
|
2710
Traeger
COOK
$178M
| $49.9K | ﹤0.01% |
18,263
+6,753
| +59% | +$18.4K |
|
2711
ALX Oncology
ALXO
$62.7M
| $49.2K | ﹤0.01% |
+10,257
| New | +$49.2K |
|
2712
TScan Therapeutics
TCRX
$104M
| $49.2K | ﹤0.01% |
+19,212
| New | +$49.2K |
|
2713
Oramed Pharmaceuticals
ORMP
$95.5M
| $49K | ﹤0.01% |
18,764
+6,975
| +59% | +$18.2K |
|
2714
Quantum-Si Incorporated
QSI
$243M
| $46.8K | ﹤0.01% |
+28,169
| New | +$46.8K |
|
2715
Trevi Therapeutics
TRVI
$1.17B
| $46.7K | ﹤0.01% |
+21,427
| New | +$46.7K |
|
2716
Larimar Therapeutics
LRMR
$342M
| $46K | ﹤0.01% |
+11,646
| New | +$46K |
|
2717
Inotiv
NOTV
$47.8M
| $45.9K | ﹤0.01% |
+14,904
| New | +$45.9K |
|
2718
Telos
TLS
$469M
| $45.7K | ﹤0.01% |
19,134
+7,985
| +72% | +$19.1K |
|
|
TUYA
2719
Tuya Inc
TUYA
$1.53B
| $45.2K | ﹤0.01% |
29,178
| – | – |
|
|
NIU
2720
Niu Technologies
NIU
$317M
| $43.1K | ﹤0.01% |
15,226
| – | – |
|
2721
BioAtla
BCAB
$45.5M
| $42.3K | ﹤0.01% |
24,897
+6,410
| +35% | +$10.9K |
|
2722
Rackspace Technology
RXT
$337M
| $40.7K | ﹤0.01% |
+17,338
| New | +$40.7K |
|
2723
China Automotive Systems
CAAS
$141M
| $40.2K | ﹤0.01% |
10,324
| – | – |
|
2724
Kodiak Sciences
KOD
$514M
| $37.2K | ﹤0.01% |
20,654
+6,013
| +41% | +$10.8K |
|
2725
Arbutus Biopharma
ABUS
$886M
| $36.1K | ﹤0.01% |
17,773
+7,113
| +67% | +$14.4K |
|